A carregar...
Current advances in Hodgkin’s lymphoma
Hodgkin’s lymphoma is a highly treatable malignancy. It has high cure rates yet there are many patients who relapse or are refractory to treatment. Traditionally, treatment has been with conventional chemotherapy; however, the development of brentuximab vedotin and immune checkpoint inhibitors has r...
Na minha lista:
| Publicado no: | Chronic Dis Transl Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Chinese Medical Association
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6450804/ https://ncbi.nlm.nih.gov/pubmed/30993260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cdtm.2019.02.003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|